VIR Stock Summary and Trading Ideas (Vir Biotechnology | NASDAQ:VIR)

Vir Biotechnology Inc is an immunology company focused on combining cutting-edge technologies to treat and prevent serious infectious diseases and other serious conditions, including viral-associated diseases. Through internal development, collaborations, and acquisitions, it has four technology platforms, focused on antibodies, T cells, innate immunity, and small interfering ribonucleic acid, or siRNA. The company's pipeline consists of product candidates targeting hepatitis B, HBV, influenza A, human immunodeficiency virus, HIV, and tuberculosis, or TB. Its revenue sources are collaboration revenue, contract revenue, grant revenue, and license revenue.

Vir Biotechnology trades on the NASDAQ stock market under the symbol VIR.

As of December 23, 2025, VIR stock price declined to $5.99 with 1,224,075 million shares trading.

VIR has a beta of 0.73, meaning it tends to be less sensitive to market movements. VIR has a correlation of 0.03 to the broad based SPY ETF.

VIR has a market cap of $828.05 million. This is considered a Small Cap stock.

Last quarter Vir Biotechnology reported $240,000 in Revenue and -$1.17 earnings per share. This fell short of revenue expectation by $-4 million and missed earnings estimates by -$.37.

In the last 3 years, VIR traded as high as $31.55 and as low as $4.16.

The top ETF exchange traded funds that VIR belongs to (by Net Assets): IJR, VTI, VB, XBI, IWM.

VIR has underperformed the market in the last year with a price return of -18.4% while the SPY ETF gained +17.6%. However, in the short term, VIR had mixed performance relative to the market. It has outperformed in the last 3 months, returning +13.7% vs +3.5% return in SPY. But in the last 2 weeks, VIR shares have been beat by the market, returning -9.0% compared to an SPY return of +0.9%.

VIR support price is $5.70 and resistance is $6.32 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that VIR shares will trade within this expected range on the day.